(Q35204614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Gerd Dannhardt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Medicinal Chemistry

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

661-670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

Magnesium gates glutamate-activated channels in mouse central neurones

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Allosteric interactions and modulator requirement for NMDA receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

N-methyl-D-aspartic acid receptor structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Allosteric modulation of N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Molecular cloning and characterization of the rat NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Transient expression of NMDA receptor subunit NR2B in the developing rat heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Expression and role of ionotropic glutamate receptors in pancreatic islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Excitotoxicity in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Modulation of glutamate receptors: strategies for the development of novel antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Anticonvulsant action of excitatory amino acid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The NMDA receptor complex: a promising target for novel antiepileptic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Cyclooxygenase inhibitors--current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

A cure for wind up: NMDA receptor antagonists as potential analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The organization of spinal pathways to ventrobasal thalamus in an experimental model of pain (the arthritic rat). An electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Thresholds and encoding of neuronal responses to mechanical stimuli in the ventro-basal thalamus during carrageenin-induced hyperalgesic inflammation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

NMDA receptor antagonists as analgesics: focus on the NR2B subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Neuroactive amino acids in focally epileptic human brain: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The pharmacology and mechanism of action of riluzole

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Felbamate in experimental model of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Synthesis of tricyclic indole-2-carboxylic [correction of caboxylic] acids as potent NMDA-glycine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

SM-31900, a novel NMDA receptor glycine-binding site antagonist, reduces infarct volume induced by permanent middle cerebral artery occlusion in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Glutamatergic mechanisms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Efficacy of newer generation antipsychotics in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Adjunctive high-dose glycine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

D-serine added to antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Placebo-controlled trial of glycine added to clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Management of negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Selective agonists and antagonists for kainate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

LY404187: A Novel Positive Allosteric Modulator of AMPA Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Specific and non-specific effects of neuro-excitatory amino acids on learning and other behaviours in the chicken

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Synaptic plasticity. The role of NMDA receptors in learning and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

A correlative study on hippocampal cation shifts and amino acids and clinico-pathological data in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

[3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Novel glycineB antagonists show neuroprotective activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

d-Cycloserine enhances implicit memory in Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

D-cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Restorative effects of glutamate antagonists in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900113-2

7 January 2021

10.1016/S0223-5234(03)00113-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12932897%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference